Literature DB >> 6667063

"Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization.

J Benavides, C Malgouris, F Imbault, F Begassat, A Uzan, C Renault, M C Dubroeucq, C Gueremy, G Le Fur.   

Abstract

PK 11195 [1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinec arboxamide] is a compound chemically unrelated to benzodiazepines with a high affinity for the "peripheral type" binding sites for benzodiazepines (Le Fur et al., 1983a). [3H]PK 11195 binds to the adrenal membranes with a high affinity (KD congruent to 3 nM) in a specific, reversible and GABA-independent manner. Binding is also characterized by very high Bmax (34 pmol/mg protein). These binding sites are the "peripheral type" benzodiazepine binding sites as demonstrated by the potency order of displacement of the [3H]PK 11195 bound: PK 11195 greater than R05-4864 greater than diazepam greater than dipyridamole greater than clonazepam. The biochemical characteristic of the binding to rat adrenal sections has also been studied. In these conditions the affinity for [3H]PK 11195 is ten times smaller, but the potency order of displacing agents was the same, demonstrating the identity of the section binding sites. Using tritium sensitive film these sites have been visualized in adrenal sections. [3H]PK 11195 binding sites are localized in the adrenal cortex with some spare labelling in the medulla.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667063

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  16 in total

1.  Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography.

Authors:  K Hashimoto; O Inoue; K Suzuki; T Yamasaki; M Kojima
Journal:  Ann Nucl Med       Date:  1989-07       Impact factor: 2.668

2.  Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.

Authors:  Daniel García-Lorenzo; Sonia Lavisse; Claire Leroy; Catriona Wimberley; Benedetta Bodini; Philippe Remy; Mattia Veronese; Federico Turkheimer; Bruno Stankoff; Michel Bottlaender
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-09       Impact factor: 6.200

3.  Putative diazepam binding inhibitor peptide: cDNA clones from rat.

Authors:  I Mocchetti; R Einstein; J Brosius
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 4.  Minireview: translocator protein (TSPO) and steroidogenesis: a reappraisal.

Authors:  Vimal Selvaraj; Douglas M Stocco; Lan N Tu
Journal:  Mol Endocrinol       Date:  2015-03-02

Review 5.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Prog Neurobiol       Date:  2006-12-06       Impact factor: 11.685

6.  Differential effects of anxiogenic central and peripheral benzodiazepine receptor ligands in tests of learning and memory.

Authors:  P V Holmes; R C Drugan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Comparison of the effects of chlordiazepoxide and CL 218,872 on serum corticosterone concentrations in rats.

Authors:  J F McElroy; J M Miller; J S Meyer
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Allosteric modulation by benzodiazepines of GABA-gated chloride channels of an identified insect motor neurone.

Authors:  Steven D Buckingham; Yoshiaki Higashino; David B Sattelle
Journal:  Invert Neurosci       Date:  2009-10-22

Review 9.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair.

Authors:  Ming-Kai Chen; Tomás R Guilarte
Journal:  Pharmacol Ther       Date:  2008-02-09       Impact factor: 12.310

10.  Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS).

Authors:  Filomena Mattner; Karine Mardon; Andrew Katsifis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.